Drugs that contain Halobetasol Propionate; Tazarotene
1. Drug name - DUOBRII
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10478502 | BAUSCH | Pharmaceutical formulations containing corticosteroids for topical administration |
Nov, 2031
(9 years from now) | |
| US8809307 | BAUSCH | Pharmaceutical formulations containing corticosteroids for topical administration |
Nov, 2031
(9 years from now) | |
| US10426787 | BAUSCH | Topical compositions and methods for treating psoriasis |
Jun, 2036
(13 years from now) | |
| US10251895 | BAUSCH | Topical compositions and methods for treating psoriasis |
Jun, 2036
(13 years from now) | |
Treatment: Topical treatment of plaque psoriasis in adults
Dosage: LOTION;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.01%;0.045% | LOTION;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.